Cơ Chế Tác Dụng :
Nova22007 is an investigational drug developed by Novagali for the treatment of dry eye and vernal keratoconjunctivitis (VKC). It is a Cyclosporine A ophthalmic product intended to be used to treat patients suffering from moderate-to-severe Dry Eye Syndrome.
Nova22007 is a proprietary cationic emulsion enabling an optimal penetration of Cyclosporine A in tissues of the eye surface that benefit from Novasorb cationic emulsion technology features.
Chỉ Định :
Investigated for use/treatment in allergic reaction and eye disorders/infections.